Company profile
LIPELLA PHARMACEUTICALS INC. CIK 1347242
Ticker
LIPO (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Pittsburgh, PA 15208
Fiscal year end
2024 (FY)
Key Financials
Revenue
$536.4K
Net income
-$5.02M
Total assets
$2.67M
Total liabilities
$754.4K
Stockholders' equity
$1.92M
Cash & equivalents
$2.18M
Operating income
-$5.08M
Operating cash flow
-$3.95M
Capital expenditures
—
Fiscal year 2024, via 10-K filed 2025-03-28. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-947.2%
Net margin
-935.2%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
28.2%
Equity / assets
71.8%
CapEx / revenue
—
Operating cash flow / net income
0.79×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
$536.4K
-$5.02M
$2.67M
$754.4K
$1.92M
2023
$449.6K
-$4.62M
$3.58M
$432.7K
$3.14M
2022
$184.2K
-$2.60M
$5.95M
$1.27M
$4.68M
2021
$259.3K
-$1.87M
$2.01M
$589.3K
$1.42M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-07-15
Financials filed via
Form 10-K
filed 2025-03-28
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Pittsburgh, PA 15208
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:52 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.